Literature DB >> 8662530

Functional mimicry of a protein hormone by a peptide agonist: the EPO receptor complex at 2.8 A.

O Livnah1, E A Stura, D L Johnson, S A Middleton, L S Mulcahy, N C Wrighton, W J Dower, L K Jolliffe, I A Wilson.   

Abstract

The functional mimicry of a protein by an unrelated small molecule has been a formidable challenge. Now, however, the biological activity of a 166-residue hematopoietic growth hormone, erythropoietin (EPO), with its class 1 cytokine receptor has been mimicked by a 20-residue cyclic peptide unrelated in sequence to the natural ligand. The crystal structure at 2.8 A resolution of a complex of this agonist peptide with the extracellular domain of EPO receptor reveals that a peptide dimer induces an almost perfect twofold dimerization of the receptor. The dimer assembly differs from that of the human growth hormone (hGH) receptor complex and suggests that more than one mode of dimerization may be able to induce signal transduction and cell proliferation. The EPO receptor binding site, defined by peptide interaction, corresponds to the smaller functional epitope identified for hGH receptor. Similarly, the EPO mimetic peptide ligand can be considered as a minimal hormone, and suggests the design of nonpeptidic small molecule mimetics for EPO and other cytokines may indeed be achievable.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8662530     DOI: 10.1126/science.273.5274.464

Source DB:  PubMed          Journal:  Science        ISSN: 0036-8075            Impact factor:   47.728


  100 in total

1.  Dimerization of zinc fingers mediated by peptides evolved in vitro from random sequences.

Authors:  B S Wang; C O Pabo
Journal:  Proc Natl Acad Sci U S A       Date:  1999-08-17       Impact factor: 11.205

2.  Activation of erythropoietin receptor in the absence of hormone by a peptide that binds to a domain different from the hormone binding site.

Authors:  T Naranda; K Wong; R I Kaufman; A Goldstein; L Olsson
Journal:  Proc Natl Acad Sci U S A       Date:  1999-06-22       Impact factor: 11.205

3.  Mimicking dominant negative inhibition of prion replication through structure-based drug design.

Authors:  V Perrier; A C Wallace; K Kaneko; J Safar; S B Prusiner; F E Cohen
Journal:  Proc Natl Acad Sci U S A       Date:  2000-05-23       Impact factor: 11.205

Review 4.  Receptor recognition by gp130 cytokines.

Authors:  J Bravo; J K Heath
Journal:  EMBO J       Date:  2000-06-01       Impact factor: 11.598

5.  The signal transducer gp130: solution structure of the carboxy-terminal domain of the cytokine receptor homology region.

Authors:  T Kernebeck; S Pflanz; G Müller-Newen; G Kurapkat; R M Scheek; K Dijkstra; P C Heinrich; A Wollmer; S Grzesiek; J Grötzinger
Journal:  Protein Sci       Date:  1999-01       Impact factor: 6.725

6.  Rotational coupling of the transmembrane and kinase domains of the Neu receptor tyrosine kinase.

Authors:  C A Bell; J A Tynan; K C Hart; A N Meyer; S C Robertson; D J Donoghue
Journal:  Mol Biol Cell       Date:  2000-10       Impact factor: 4.138

Review 7.  Search and discovery strategies for biotechnology: the paradigm shift.

Authors:  A T Bull; A C Ward; M Goodfellow
Journal:  Microbiol Mol Biol Rev       Date:  2000-09       Impact factor: 11.056

8.  Binding of small molecules to an adaptive protein-protein interface.

Authors:  Michelle R Arkin; Mike Randal; Warren L DeLano; Jennifer Hyde; Tinh N Luong; Johan D Oslob; Darren R Raphael; Lisa Taylor; Jun Wang; Robert S McDowell; James A Wells; Andrew C Braisted
Journal:  Proc Natl Acad Sci U S A       Date:  2003-02-11       Impact factor: 11.205

9.  Structural basis for recognition by an in vitro evolved affibody.

Authors:  Martin Högbom; Malin Eklund; Per-Ake Nygren; Pär Nordlund
Journal:  Proc Natl Acad Sci U S A       Date:  2003-02-25       Impact factor: 11.205

Review 10.  Structure and function of interleukin-22 and other members of the interleukin-10 family.

Authors:  Daniela Barretto Barbosa Trivella; José Ribamar Ferreira-Júnior; Laure Dumoutier; Jean-Christophe Renauld; Igor Polikarpov
Journal:  Cell Mol Life Sci       Date:  2010-05-08       Impact factor: 9.261

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.